Presenting
Open Orphan
Open Orphan (ORPH) is a rapidly growing niche CRO pharmaceutical services company which is the world leader in testing vaccines and antivirals through the use of human challenge clinical trials. Open Orphan is actively involved in the fight against COVID-19.
Shield Therapeutics
Shield is a commercial stage, specialty pharmaceutical company delivering innovative pharmaceuticals to address patients unmet medical needs. The Groups lead product, Feraccru®/Accrufer® is approved for the treatment of iron deficiency in adults in the EU, USA and Switzerland. In Europe it is marketed as Feraccru® by Norgine and in the USA the product will be marketed as Accrufer®. Shield also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co. Ltd for the development and commercialisation of Feraccru®/Accrufer® in China.
Silence Therapeutics
Silence Therapeutics is a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases.
